Shares of this Small-cap pharma company jumped over 9 per cent today!

This company has introduced 1000 mg dispersible tablet for the first time in the world. This tablet can get dispersed in around 90 seconds.

Shares of Shilpa Medicare opened on Friday at Rs 267.95 and has touched its day high at Rs 298.75 on BSE and after a jump by huge 9 per cent. During last week, the stock touched a high of Rs 299.00 and low of Rs 263.95. The stock is currently trading at Rs 293.00 a piece.

Management of the company has updated that, Capecitabine 1000 MG dispersible tablets from Shilpa Medicare are the first of their kind in the world, including cutting-edge technology for quicker dispersion within 90 seconds. On December 16, 2022, the firm introduced the product to the Indian market. Through its partners and clients, the company is now planning to launch Capebel 1 gm DT in a few foreign countries.

Capecitabine is currently available in 500 mg and 150 mg tablets, and the suggested dose is 3500 to 4000 mg/day divided into two doses for 14 straight days. This means that patients must take 7 to 8 tablets per day. For cancer patients, this is still a significant unmet need. Since most cancer patients have trouble swallowing, taking 7 to 8 tablets every day presents a problem and negatively impacts patient compliance.

Shilpa Medicare is a company that produces high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery System, Peptides, Biotech goods, and Specialty chemicals utilising cutting-edge technology. One of the top manufacturers and providers of intermediates and APIs for oncology and non-oncology products is SML.

This BSE group “A” stock touched its 52-week High at Rs 605.00 whereas the 52-week low stood at Rs 263.95. Presently, the promoters are holding 50.01 per cent stake of the company, while Institution and Non-Institutions are holding 16.22 per cent and 33.77 per cent stake, respectively.

The market cap of the company stood at Rs 2,499.89 crore.